Literature DB >> 20304674

Electron transfer dissociation with supplemental activation to differentiate aspartic and isoaspartic residues in doubly charged peptide cations.

Wai Yi Kelly Chan1, T W Dominic Chan, Peter B O'Connor.   

Abstract

Electron-transfer dissociation (ETD) with supplemental activation of the doubly charged deamidated tryptic digested peptide ions allows differentiation of n class="Chemical">isoaspartic acid and aspartic acid residues using the c + 57 or z*-57 peaks. The diagnostic peak clearly localizes and characterizes the isoaspartic acid residue. Supplemental activation in ETD of the doubly charged peptide ions involves resonant excitation of the charge reduced precursor radical cations and leads to further dissociation, including extra backbone cleavages and secondary fragmentation. Supplemental activation is essential to obtain a high quality ETD spectrum (especially for doubly charged peptide ions) with sequence information. Unfortunately, the low-resolution of the ion trap mass spectrometer makes detection of the diagnostic peak, [M-60], for the aspartic acid residue difficult due to interference with side-chain loss from arginine and glutamic acid residues. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20304674      PMCID: PMC3114307          DOI: 10.1016/j.jasms.2010.02.002

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  19 in total

1.  Identification of aspartic and isoaspartic acid residues in amyloid beta peptides, including Abeta1-42, using electron-ion reactions.

Authors:  Nadezda P Sargaeva; Cheng Lin; Peter B O'Connor
Journal:  Anal Chem       Date:  2009-12-01       Impact factor: 6.986

2.  Molecular clocks.

Authors:  N E Robinson; A B Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

3.  Selective deamidation of recombinant human stem cell factor during in vitro aging: isolation and characterization of the aspartyl and isoaspartyl homodimers and heterodimers.

Authors:  Y R Hsu; W C Chang; E A Mendiaz; S Hara; D T Chow; M B Mann; K E Langley; H S Lu
Journal:  Biochemistry       Date:  1998-02-24       Impact factor: 3.162

4.  Deamidation: Differentiation of aspartyl from isoaspartyl products in peptides by electron capture dissociation.

Authors:  Jason J Cournoyer; Jason L Pittman; Vera B Ivleva; Eric Fallows; Lucy Waskell; Catherine E Costello; Peter B O'Connor
Journal:  Protein Sci       Date:  2005-02       Impact factor: 6.725

5.  Prediction of protein deamidation rates from primary and three-dimensional structure.

Authors:  N E Robinson; A B Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 6.  Isoaspartate formation and neurodegeneration in Alzheimer's disease.

Authors:  T Shimizu; A Watanabe; M Ogawara; H Mori; T Shirasawa
Journal:  Arch Biochem Biophys       Date:  2000-09-15       Impact factor: 4.013

7.  Characterization of a beta-Asp33 isoform of recombinant hirudin sequence variant 1 by low-energy collision-induced dissociation.

Authors:  P Schindler; D Müller; W Märki; H Grossenbacher; W J Richter
Journal:  J Mass Spectrom       Date:  1996-09       Impact factor: 1.982

8.  Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation.

Authors:  T Geiger; S Clarke
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

9.  Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins.

Authors:  S Clarke
Journal:  Int J Pept Protein Res       Date:  1987-12

10.  Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.

Authors:  A E Roher; J D Lowenson; S Clarke; C Wolkow; R Wang; R J Cotter; I M Reardon; H A Zürcher-Neely; R L Heinrikson; M J Ball
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

View more
  18 in total

1.  Evaluation of MALDI-TOF/TOF Mass Spectrometry Approach for Quantitative Determination of Aspartate Residue Isomerization in the Amyloid-β Peptide.

Authors:  Stanislav I Pekov; Daniil G Ivanov; Anna E Bugrova; Maria I Indeykina; Natalia V Zakharova; Igor A Popov; Alexey S Kononikhin; Sergey A Kozin; Alexander A Makarov; Evgeny N Nikolaev
Journal:  J Am Soc Mass Spectrom       Date:  2019-05-09       Impact factor: 3.109

2.  A Retrospective Evaluation of the Use of Mass Spectrometry in FDA Biologics License Applications.

Authors:  Sarah Rogstad; Anneliese Faustino; Ashley Ruth; David Keire; Michael Boyne; Jun Park
Journal:  J Am Soc Mass Spectrom       Date:  2016-11-21       Impact factor: 3.109

3.  Differentiating N-terminal aspartic and isoaspartic acid residues in peptides.

Authors:  Nadezda P Sargaeva; Cheng Lin; Peter B O'Connor
Journal:  Anal Chem       Date:  2011-08-01       Impact factor: 6.986

4.  Top-down study of β2-microglobulin deamidation.

Authors:  Xiaojuan Li; Xiang Yu; Catherine E Costello; Cheng Lin; Peter B O'Connor
Journal:  Anal Chem       Date:  2012-06-29       Impact factor: 6.986

Review 5.  Radical solutions: Principles and application of electron-based dissociation in mass spectrometry-based analysis of protein structure.

Authors:  Frederik Lermyte; Dirk Valkenborg; Joseph A Loo; Frank Sobott
Journal:  Mass Spectrom Rev       Date:  2018-02-09       Impact factor: 10.946

Review 6.  Electron transfer dissociation mass spectrometry in proteomics.

Authors:  Min-Sik Kim; Akhilesh Pandey
Journal:  Proteomics       Date:  2012-01-23       Impact factor: 3.984

7.  Comparison of Collisional and Electron-Based Dissociation Modes for Middle-Down Analysis of Multiply Glycosylated Peptides.

Authors:  Kshitij Khatri; Yi Pu; Joshua A Klein; Juan Wei; Catherine E Costello; Cheng Lin; Joseph Zaia
Journal:  J Am Soc Mass Spectrom       Date:  2018-04-16       Impact factor: 3.109

8.  Integrated proteomic analysis of major isoaspartyl-containing proteins in the urine of wild type and protein L-isoaspartate O-methyltransferase-deficient mice.

Authors:  Shujia Dai; Wenqin Ni; Alexander N Patananan; Steven G Clarke; Barry L Karger; Zhaohui Sunny Zhou
Journal:  Anal Chem       Date:  2013-02-06       Impact factor: 6.986

Review 9.  Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars.

Authors:  Steven A Berkowitz; John R Engen; Jeffrey R Mazzeo; Graham B Jones
Journal:  Nat Rev Drug Discov       Date:  2012-06-29       Impact factor: 84.694

10.  In-Source Decay Characterization of Isoaspartate and β-Peptides.

Authors:  Xiang Yu; Nadezda P Sargaeva; Christopher J Thompson; Catherine E Costello; Cheng Lin
Journal:  Int J Mass Spectrom       Date:  2015-11-15       Impact factor: 1.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.